Updated efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion lung cancer Meeting Abstract
| Authors: | Drilon, A. E.; Lin, J. J.; Kummar, S.; Tan, D. S. W.; Patel, J. D.; Lassen, U. N.; Leyvraz, S.; Moreno, V.; Rosen, L. S.; Solomon, B. M.; Yachnin, J.; Liu, Y.; Dai, M. S.; Norenberg, R.; Fellous, M. M.; Mussi, C. E.; Shen, L. |
| Abstract Title: | Updated efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion lung cancer |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680302213 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2022.40.16_suppl.9024 |
| Notes: | Meeting Abstract: 9024 -- This meeting was also held virtually -- Source: Wos |
